Cogent Biosciences signs commercial supply agreement with Hovione for bezuclastinib
Cogent Biosciences entered a Commercial Supply Agreement with Hovione to manufacture bezuclastinib spray-dried dispersion and tablets. Deal uses rolling quarterly forecasts with a binding near-term portion and minimum, declining purchase requirements.
Cogent Biosciences entered into a Commercial Supply Agreement with Hovione to manufacture bezuclastinib spray-dried dispersion and tablets.
The pact uses rolling quarterly forecasts with a binding near-term portion and requires Cogent to purchase minimum, declining percentages of its product needs…